This meeting is a unique opportunity to learn about new strategies to lower cardiovascular risk, heart failure hospitalisation and mortality in type 2 diabetes patients by using novel anti-diabetes agent. Benefits, rational indications and potential side effects will be discussed by experts in the field.
About this section
The purpose of the Endocrinology & Diabetes Section is to promote the discussion and further the interest of all aspects of endocrinology and diabetes. Meetings plan to explore current concepts and innovations in the field of endocrinology helping clinicians and scientist maintain their training and keep ahead in new developments.
Please note this event has been cancelled.
Professor Ketan Dhatariya